Back to Journals » Journal of Asthma and Allergy » Volume 17

Review

Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types

       
Total article views   HTML views PDF downloads Totals
2,124 Dovepress* 2,057+ 66 2,123
PubMed Central* 67 44 111
Totals 2,124 110 2,234
*Since 19 March 2024

View citations on PubMed Central and Google Scholar